Skip to content
CancerIndex

Publication

FLT3 mutations as diagnostic and prognostic biomarkers in acute myeloid leukemia.

Riya Thapa, Neeraj Kumar Fuloria, Asif Ahmad Bhat, Omji Porwal, Mohammed Tahir Ansari, Kamal Narain, Anupam Biswas, Sangita Biswas, Sumita Bhatia, Shivkanya Fuloria

Clinica chimica acta; international journal of clinical chemistrySep 15, 2026PMID 42235731doi:10.1016/j.cca.2026.121132 Journal ArticleReviewpubmedProvenance
Source
PubMed
Retrieved
Sep 28, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260928-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Acute myeloid leukemia (AML) is a diverse and complex haematological cancer that cannot be fully characterized, even with the combination of morphology and cytogenetics. As a result, molecular biomarkers have become the focus of diagnosis, risk stratification, therapeutic planning and monitoring of…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.